Post-approval studies (Phase 4)Study completedNCT00950170
What this trial is testing
Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting
Who this might be right for
Hemophilia A
Pfizer 23